Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


11.10.2021

1 Am J Physiol Lung Cell Mol Physiol
1 Am J Respir Cell Mol Biol
2 Am J Respir Crit Care Med
2 Anatol J Cardiol
1 Arkh Patol
1 Br J Pharmacol
1 Chest
2 Curr Probl Cardiol
1 Fundam Clin Pharmacol
1 Heart Lung
1 Heart Vessels
1 J Am Heart Assoc
1 J Card Fail
1 J Cardiothorac Vasc Anesth
1 J Cell Mol Med
1 J Clin Invest
1 JACC Cardiovasc Imaging
1 JACC Cardiovasc Interv
1 Joint Bone Spine
1 Laryngoscope
1 Life Sci
1 Metabolomics
1 Pan Afr Med J
2 Pulm Circ
1 Pulm Pharmacol Ther
2 Respirology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Physiol Lung Cell Mol Physiol

  1. WESTOO C, Norvik C, Peruzzi N, van der Have O, et al
    Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L17-L28.
    PubMed         Abstract available


    Am J Respir Cell Mol Biol

  2. MARGAROLI C, Russell D
    Extracellular Vesicles: Progress and Challenges in the Study of Human Immunodeficiency Virus and Cocaine-associated Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2021;65:341-342.
    PubMed        


    Am J Respir Crit Care Med

  3. HASSOUN PM, Farber HW
    Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
    Am J Respir Crit Care Med. 2021;204:755-756.
    PubMed        

  4. CASCINO TM, McLaughlin VV
    Upfront Combination Therapy for Pulmonary Arterial Hypertension: Time to Be More Ambitious than AMBITION.
    Am J Respir Crit Care Med. 2021;204:756-759.
    PubMed        


    Anatol J Cardiol

  5. EROL C
    Energy drinks, pulmonary hypertension, and many more.
    Anatol J Cardiol. 2021;25:677.
    PubMed        

  6. DEMIREL M, Kulahcioglu S, Tokgoz HC, Akbal OY, et al
    Impaired endothelium-dependent and endothelium-independent systemic vasodilatory reserve in pulmonary hypertension regardless the clinical group: A generalized dysfunction beyond the pulmonary arteries?
    Anatol J Cardiol. 2021;25:733-740.
    PubMed         Abstract available


    Arkh Patol

  7. KHUGAEV GA, Shmalts AA
    [Morphological assessment of pulmonary vessels in pulmonary arterial hypertension associated with congenital heart disease].
    Arkh Patol. 2021;83:49-57.
    PubMed         Abstract available


    Br J Pharmacol

  8. ZHENG Q, Lu W, Yan H, Duan X, et al
    Combination Treatment by HIF-2alpha Antagonist and P53 Agonist Reverses Established Pulmonary Hypertension.
    Br J Pharmacol. 2021 Oct 2. doi: 10.1111/bph.15696.
    PubMed         Abstract available


    Chest

  9. BRITTAIN EL, Callahan SJ
    Finding Needles in a Haystack: Progress Toward Identifying Pulmonary Arterial Hypertension With the Use of Administrative Data.
    Chest. 2021;159:1713-1714.
    PubMed        


    Curr Probl Cardiol

  10. TORRES-ROJAS MB, Porres-Aguilar M, Mukherjee D, Cueto-Robledo G, et al
    Takayasu's arteritis as a rare cause of group 4 pulmonary hypertension.
    Curr Probl Cardiol. 2021 Sep 29:101008. doi: 10.1016/j.cpcardiol.2021.101008.
    PubMed        

  11. CUETO-ROBLEDO G, Porres-Aguilar M, Puebla-Aldama D, Barragan-Martinez MDP, et al
    Severe pulmonary hypertension: An important sequel after severe post-acute COVID-19 pneumonia.
    Curr Probl Cardiol. 2021 Sep 30:101004. doi: 10.1016/j.cpcardiol.2021.101004.
    PubMed        


    Fundam Clin Pharmacol

  12. ALA M, Mohammad Jafari R, Dehpour AR
    Sildenafil Beyond Erectile Dysfunction and Pulmonary Arterial Hypertension: Thinking About New Indications.
    Fundam Clin Pharmacol. 2020 Nov 23. doi: 10.1111/fcp.12633.
    PubMed         Abstract available


    Heart Lung

  13. CHAO HY, Hsu CH, Wang ST, Yu CY, et al
    Mediating effect of social support on the relationship between illness concealment and depression symptoms in patients with pulmonary arterial hypertension.
    Heart Lung. 2021;50:706-713.
    PubMed         Abstract available


    Heart Vessels

  14. YAMAKAWA N, Kotooka N, Kato T, Kuroda T, et al
    Cardiac acoustic biomarkers as surrogate markers to diagnose the phenotypes of pulmonary hypertension: an exploratory study.
    Heart Vessels. 2021 Oct 1. pii: 10.1007/s00380-021-01943.
    PubMed         Abstract available


    J Am Heart Assoc

  15. DALY CM, Griffiths M, Simpson CE, Yang J, et al
    Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
    J Am Heart Assoc. 2021 Oct 8:e021409. doi: 10.1161/JAHA.120.021409.
    PubMed         Abstract available


    J Card Fail

  16. GULATI G, Ruthazer R, Denofrio D, Vest AR, et al
    Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.
    J Card Fail. 2021;27:552-559.
    PubMed         Abstract available


    J Cardiothorac Vasc Anesth

  17. WOLLA CD, Matos JR, Wineland R
    Anesthetic Management of Severe Pulmonary Hypertension in Pregnancy.
    J Cardiothorac Vasc Anesth. 2021 Sep 17. pii: S1053-0770(21)00830.
    PubMed         Abstract available


    J Cell Mol Med

  18. LIU J, Ke X, Wang L, Zhang Y, et al
    Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1.
    J Cell Mol Med. 2021;25:4732-4743.
    PubMed         Abstract available


    J Clin Invest

  19. WOO KV, Shen IY, Weinheimer CJ, Kovacs A, et al
    Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension.
    J Clin Invest. 2021;131.
    PubMed         Abstract available


    JACC Cardiovasc Imaging

  20. GOH ZM, Alabed S, Shahin Y, Rothman AMK, et al
    Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2021;14:1271-1272.
    PubMed        


    JACC Cardiovasc Interv

  21. TOI S, Ikeda N, Iijima R, Hara H, et al
    Successful Transcollateral Bidirectional Balloon Pulmonary Angioplasty in a Patient With Chronic Thromboembolic Pulmonary Hypertension.
    JACC Cardiovasc Interv. 2021 Sep 22. pii: S1936-8798(21)01442.
    PubMed        


    Joint Bone Spine

  22. ZHANG Y, Qin D, Li Q, Yang X, et al
    Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: a systematic review and meta-analysis.
    Joint Bone Spine. 2021 Sep 30:105287. doi: 10.1016/j.jbspin.2021.105287.
    PubMed         Abstract available


    Laryngoscope

  23. CLEMENTS AC, Walsh JM, Dai X, Skinner ML, et al
    Cardiopulmonary Testing before Pediatric Adenotonsillectomy for Severe and Very Severe Obstructive Sleep Apnea Syndrome.
    Laryngoscope. 2021;131:2361-2368.
    PubMed         Abstract available


    Life Sci

  24. ZIMMER A, Teixeira RB, Constantin RL, Fernandes-Piedras TRG, et al
    Thioredoxin system activation is associated with the progression of experimental pulmonary arterial hypertension.
    Life Sci. 2021;284:119917.
    PubMed         Abstract available


    Metabolomics

  25. CHOUDHURY P, Bhattacharya A, Dasgupta S, Ghosh N, et al
    Identification of novel metabolic signatures potentially involved in the pathogenesis of COPD associated pulmonary hypertension.
    Metabolomics. 2021;17:94.
    PubMed         Abstract available


    Pan Afr Med J

  26. TAKSANDE A, Jameel PZ, Pujari D, Taksande B, et al
    Variation in pulmonary function tests among children with sickle cell anemia: a systematic review and meta-analysis.
    Pan Afr Med J. 2021;39:140.
    PubMed         Abstract available


    Pulm Circ

  27. CHEN DD, Hu WP, Xie L, Xiang GL, et al
    Serum cartilage oligomeric matrix protein is decreased in patients with pulmonary hypertension: a potential protective factor.
    Pulm Circ. 2021;11:0271678X20978861.
    PubMed         Abstract available

  28. HAGENBURG J, Savale L, Lechartier B, Ghigna MR, et al
    Pulmonary hypertension associated with busulfan.
    Pulm Circ. 2021;11:20458940211030170.
    PubMed         Abstract available


    Pulm Pharmacol Ther

  29. NABEH OA, Matter LM, Khattab MA, Esraa Menshawey, et al
    "The possible implication of endothelin blockers in the management of COVID19-induced pulmonary hypertension".
    Pulm Pharmacol Ther. 2021 Sep 30:102082. doi: 10.1016/j.pupt.2021.102082.
    PubMed         Abstract available


    Respirology

  30. SAYEGH ALC, Silva BM, Ferreira EVM, Ramos RP, et al
    Clinical utility of ventilatory and gas exchange evaluation during low-intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension.
    Respirology. 2021;26:264-272.
    PubMed         Abstract available

  31. KEARNEY K, Gold J, Corrigan C, Dhital K, et al
    Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry.
    Respirology. 2021 Oct 5. doi: 10.1111/resp.14162.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: